Searched for
FDA LIMITATIONS ON VACCINE
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- FDA memo on pediatric COVID-19 vaccine deaths sparks concern, expert debateA leaked FDA memo alleging at least 10 pediatric COVID-19 vaccine deaths, citing myocarditis without data, has sparked alarm. This comes as...
- FDA approves updated COVID-19 shots but limits access for some kids and adultsU.S. regulators have approved updated COVID-19 shots from Pfizer, Moderna, and Novavax, but access is now limited for younger adults and ch...
- FDA panel debates COVID-19 vaccine recipe as questions swirl about fall shotsGovernment advisers are convening to discuss potential COVID-19 vaccine updates for the fall and winter, amidst a new policy that limits ro...
- Trump’s FDA just changed COVID vaccine rules for 2025 — will you still qualify for boosters under the new guidelines?FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and high-risk ind...
- Moderna pulls application for COVID-flu combination shotModerna has withdrawn its application for a combination flu and COVID vaccine, awaiting efficacy data from a late-stage influenza shot tria...
- New Trump vaccine policy might limit access to your future COVID shots: 10 pointsThe US Food and Drug Administration changes Covid-19 vaccine approval process. Access to seasonal boosters is restricted for healthy indivi...
- US to limit Covid-19 boosters to over-65s or those at high riskUS health officials announced a shift in Covid-19 booster policy, limiting routine doses to those over 65 or at high risk. New placebo-cont...
- US approves first vaccine against chikungunya virusThe vaccine, developed by Europe's Valneva which will be marketed under the name Ixchiq, was approved for people 18 and over who are at inc...
- FDA restricts J&J's COVID-19 vaccine due to blood clot riskThe FDA authorised J&J's shot in February last year for adults 18 and up. The vaccine was initially considered an important tool in fightin...
- FDA OKs another Pfizer, Moderna COVID booster for 50 and upUntil now, the FDA had cleared fourth doses only for people 12 and older who have severely weakened immune systems. The agency said this es...
- US to lift all travel restrictions for incoming foreign nationals from November 8To further strengthen protections, unvaccinated travellers - whether US Citizens, lawful permanent residents (LPRs), or the small number of...
- Data from federal scientists raise questions about J&J booster shotsSome scientists question how the federal government is considering boosters of any brand, given the limited data provided not only by Johns...
- Pfizer, Moderna vaccines may soon be available in IndiaThe Drugs Controller General of India (DCGI) has done away with specific trials of COVID-19 vaccines that have been approved by other inter...
- US advisers endorse single-shot Covid-19 vaccine from J&JJ&J's vaccine protects against the worst effects of Covid-19 after one shot, and it can be stored up to three months at refrigerator temper...
- America says coronavirus vaccine to start arriving in states from MondayTrucks will roll out Sunday morning as shipping companies UPS and FedEx begin delivering Pfizer's vaccine to nearly 150 locations, said Arm...
- Pfizer CEO confident of getting U.S. advisory panel nod for COVID-19 vaccineBourla, speaking on a call with reporters on Tuesday, also reiterated confidence in Pfizer's ability to deliver its mRNA vaccine, developed...
- Joe Biden to let health experts decide who will get a Covid-19 vaccine first: Dr. Celine GounderSince the risk for COVID-19 can vary among different groups of people, prioritisation for a vaccine will be tricky, and Biden will leave th...
- Pfizer seeking emergency use of its COVID-19 vaccine in USThe action comes days after Pfizer Inc and its German partner BioNTech announced that its vaccine appears 95 per cent effective at preventi...
Load More
